Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of RO7049389 in Healthy Volunteers and Chronic Hepatitis B Virus (HBV) Infected Participants [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated the safety, tolerability, pharmacokinetics and pharmacodynamics of RO7049389 in healthy volunteers and chronic hepatitis B patients…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• RO7049389

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2024-10-31